Pacific Parkinson’s Research Institute (PPRI) Announces the Launch of the PPRI Leadership Fund for Excellence in Parkinson’s Disease Research

Parkinson’s disease affects more than 17,500 British Columbians, with thousands more family members and caregivers impacted daily by the challenges of the progressive neurological disorder. The Pacific Parkinson’s Research Institute (PPRI), a Vancouver-based charitable organization, has for over 30 years been at the forefront of supporting groundbreaking research into Parkinson’s disease. PPRI has enabled pioneering Parkinson’s studies in genetics, imaging, and new therapies that are having a global impact.

New Research Fund Honours Former PPRI Leaders

The newly-established PPRI Leadership Fund for Excellence in Parkinson’s Disease Research honours the remarkable individuals who have served PPRI in various leadership roles.

The PPRI Leadership Fund for Excellence in Parkinson’s Disease Research has been established within PPRI and will begin by supporting three groundbreaking PPRC projects at UBC:

Dale Parker, Former PPRI Chair and Board Member

  • A Phase 2 Feasibility Randomized, Placebo-Controlled Trial of a Multi-Strain Probiotic in the Treatment of Early Cognitive Impairment in Parkinson’s Disease – Budget $509,014

  • A Randomized, Controlled Trial of a Group-Based Lifestyle Intervention Program to Improve Outcomes and Reduce Health Care Costs in Parkinson’s Disease - Budget $549,102

  • Acting on Your Dreams: Building the Vancouver REM Sleep Behaviour Disorder Cohort – Budget $921,928

This fund celebrates PPRI’s enduring belief in the power of research and innovation to transform lives, ensuring that his contributions to the community will continue to inspire and create meaningful change for generations to come.

PPRI